Elliot Norry

CIK 1798117 · Chief Medical Officer · last filed 2025-02-20

Elliot Norry is a Chief Medical Officer who has filed 20 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for ADAP, was dated Feb 20, 2025. Across all open-market trades the lifetime net is −$118.2K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

20

Lifetime Open-Market Net

-$118.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adaptimmune Therapeutics PLC (ADAP) Delisted Chief Medical Officer 7,510 $0.06 $435 -$118.2K 20 2025-02-20

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-20 Adaptimmune Therapeutics PLC (ADAP) Delisted Grant (A) $0 EDGAR
2025-01-17 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −5,584 -$3.2K EDGAR
2025-01-15 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −22,195 -$12.9K EDGAR
2024-01-17 Adaptimmune Therapeutics PLC (ADAP) Delisted Grant (A) $0 EDGAR
2024-01-17 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −20,563 -$14.1K EDGAR
2024-01-12 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −11,808 -$10.0K EDGAR
2023-01-17 Adaptimmune Therapeutics PLC (ADAP) Delisted Grant (A) $0 EDGAR
2023-01-17 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −2,159 -$4.0K EDGAR
2023-01-12 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −11,292 -$19.4K EDGAR
2023-01-04 Adaptimmune Therapeutics PLC (ADAP) Delisted Sell (S) −876 -$1.5K EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.